- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 405/08 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing alicyclic rings
Patent holdings for IPC class C07D 405/08
Total number of patents in this class: 117
10-year publication summary
|
6
|
7
|
6
|
7
|
5
|
5
|
7
|
13
|
5
|
10
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Loxo Oncology, Inc. | 84 |
10 |
| Abbvie Inc. | 1800 |
7 |
| Epizyme, Inc. | 373 |
7 |
| Merck Sharp & Dohme LLC | 3742 |
5 |
| Huawei Technologies Co., Ltd. | 113006 |
4 |
| Calico Life Sciences LLC | 96 |
4 |
| Flexus Biosciences, Inc. | 13 |
3 |
| Lightwave Logic, Inc. | 60 |
3 |
| LT Materials Co., Ltd. | 408 |
3 |
| Novartis AG | 10829 |
2 |
| LG Chem, Ltd. | 17639 |
2 |
| Genentech, Inc. | 3983 |
2 |
| Janssen Pharmaceutica N.V. | 3384 |
2 |
| Syngenta Limited | 456 |
2 |
| Centre National de La Recherche Scientifique | 10442 |
2 |
| Assembly Biosciences, Inc. | 77 |
2 |
| CHDI Foundation, Inc. | 108 |
2 |
| Corcept Therapeutics, Inc. | 343 |
2 |
| Incyte Holdings Corporation | 661 |
2 |
| Schering Corporation | 451 |
2 |
| Other owners | 49 |